Phillips-Medisize Grows Clinical Manufacturing Capabilities to Meet Demand

Phillips-Medisize has announced that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.

Phillips-Medisize has announced in a Jan. 8, 2020 press release that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.

The new unit, designed to support late stage development of medium- and high-volume products and processes, is scheduled to be open in the second quarter of 2020 and will be equipped to serve clients with agile set up for cleanroom assembly and molding. The cleanroom space will be created by repurposing approximately 500 m2of floor space from the existing building. 

“This expansion accelerates the manufacture of innovative, compliant, and best-in-class products while reducing time to market and lowering launch risk for drug delivery device customers,” said John Horgan, vice-president, Global Sales and Marketing of Phillips-Medisize, in the press release. “Furthermore, it strengthens our client focus in Scandinavia by complementing the activities of our existing GID in Struer and our newest GID in Copenhagen.”

Source: Phillips-Medisize